{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T16:34:30Z","timestamp":1774802070753,"version":"3.50.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Breast cancer\u2013related lymphedema affects 700,000 breast cancer survivors in the United States. Although taxane-based chemotherapy regimens are commonly used in the treatment of breast cancer, the impact of taxanes on the lymphatic system remains poorly understood. This study aims to examine the influence of taxane-based chemotherapy on lymphatic function in breast cancer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective review of a prospectively-maintained database was performed. Consecutive patients with node positive breast cancer who underwent preoperative indocyanine green (ICG) lymphangiograms were identified. Information including patient demographics, baseline measurements, cancer characteristics, and treatment information were retrieved. Preoperative ICG lymphangiography videos were analyzed and lymphatic contractility was quantified for each subject. Multiple regions of interest were selected on each lymphatic channel and signal intensity was recorded for 3 minutes to generate contractility curves. Each lymphatic contraction was identified using a novel, systematic, and algorithmic approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-nine consecutive patients with unilateral node-positive breast cancer were included for analysis. Average patient age was 54.5 (13) years and mean BMI was 26.8 kg\/m<jats:sup>2<\/jats:sup> (4). The mean lymphatic contractility of patients who received taxane-based neoadjuvant chemotherapy was 0.7 contractions\/minute (c\/m) (n = 19) compared to 1.1 c\/m in those who received no neoadjuvant therapy (n = 10), (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.11). In subgroup analysis, patients who reported taxane induced neuropathy demonstrated significantly lower lymphatic contractility values than those who were asymptomatic or did not receive any chemotherapy (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.018).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In this study, we used a novel method for quantifying and evaluating lymphatic contractility rates in routine ICG lymphangiograms. Diminished lymphatic contractility was noted in patients who received taxane-based neoadjuvant chemotherapy compared with those who did not. Taxane-based neoadjuvant chemotherapy may adversely affect the lymphatic system in the breast cancer population. A larger patient cohort with longer follow-up time is needed to validate this finding and evaluate any potential association with breast cancer\u2013related lymphedema development.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000001884","type":"journal-article","created":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T12:15:20Z","timestamp":1552220120000},"page":"S173-S178","source":"Crossref","is-referenced-by-count":24,"title":["The Impact of Taxane-based Chemotherapy on the Lymphatic System"],"prefix":"10.1097","volume":"82","author":[{"given":"Anna Rose","family":"Johnson","sequence":"first","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melisa D.","family":"Granoff","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard T.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Padera","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Edwin L. Steele Laboratory, Massachusetts General Hospital, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Echoe M.","family":"Bouta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Edwin L. Steele Laboratory, Massachusetts General Hospital, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruv","family":"Singhal","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230922","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","year":"2013","journal-title":"Lancet Oncol"},{"key":"bib2-20230922","doi-asserted-by":"crossref","first-page":"379","DOI":"10.21037\/gs.2017.11.04","article-title":"Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments","volume":"7","year":"2018","journal-title":"Gland Surg"},{"key":"bib3-20230922","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-014-3137-x","article-title":"Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II\/III breast cancer patients","volume":"148","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"bib4-20230922","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.breast.2010.05.015","article-title":"Self-reported arm-lymphedema and functional impairment after breast cancer treatment\u2014a nationwide study of prevalence and associated factors","volume":"19","year":"2010","journal-title":"Breast"},{"key":"bib5-20230922","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/bjs.9846","article-title":"Adjuvant taxanes and the development of breast cancer-related arm lymphoedema","volume":"102","year":"2015","journal-title":"Br J Surg"},{"key":"bib6-20230922","first-page":"37","article-title":"NSABP protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel","volume":"11","year":"1997","journal-title":"Oncol Williston Park"},{"key":"bib7-20230922","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1200\/JCO.2004.09.062","article-title":"Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience","volume":"22","year":"2004","journal-title":"J Clin Oncol"},{"key":"bib8-20230922","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.10741","article-title":"Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and bowel (NSABP) protocol B-18","volume":"95","year":"2002","journal-title":"Cancer"},{"key":"bib9-20230922","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/PRS.0000000000000010","article-title":"Operative treatment of peripheral lymphedema: a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation","volume":"133","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"bib10-20230922","doi-asserted-by":"crossref","first-page":"e26946","DOI":"10.1371\/journal.pone.0026946","article-title":"Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients","volume":"6","year":"2011","journal-title":"PloS One"},{"key":"bib11-20230922","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1517\/14656566.9.15.2603","article-title":"Paclitaxel and docetaxel in the treatment of breast cancer","volume":"9","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"bib12-20230922","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/lrb.2014.0030","article-title":"Lymphedema following taxane-based chemotherapy in women with early breast cancer","volume":"12","year":"2014","journal-title":"Lymphat Res Biol"},{"key":"bib13-20230922","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1200\/JCO.2005.02.027","article-title":"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer","volume":"23","year":"2005","journal-title":"J Clin Oncol"},{"key":"bib14-20230922","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.1998.16.10.3426","article-title":"Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment","volume":"16","year":"1998","journal-title":"J Clin Oncol"},{"key":"bib15-20230922","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2125.1997.00613.x","article-title":"The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication","volume":"43","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"bib16-20230922","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/bjs.9766","article-title":"Global abnormalities in lymphatic function following systemic therapy in patients with breast cancer","volume":"102","year":"2015","journal-title":"Br J Surg"},{"key":"bib17-20230922","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jnci\/93.2.96","article-title":"Arm edema in breast cancer patients","volume":"93","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"bib18-20230922","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/CAD.0000000000000468","article-title":"Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema","volume":"28","year":"2017","journal-title":"Anticancer Drugs"},{"key":"bib19-20230922","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10549-015-3408-1","article-title":"Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort","volume":"151","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"bib20-20230922","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/ecc.12261","article-title":"The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review","volume":"25","year":"2016","journal-title":"Eur J Cancer Care (Engl)"},{"key":"bib21-20230922","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","article-title":"A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy","volume":"86","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib22-20230922","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","article-title":"Risk factors for lymphoedema in women with breast cancer: a large prospective cohort","volume":"28","year":"2016","journal-title":"Breast"},{"key":"bib23-20230922","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","journal-title":"J Biomed Inform"},{"key":"bib24-20230922","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.critrevonc.2015.04.011","article-title":"Taxane induced neuropathy in patients affected by breast cancer: literature review","volume":"96","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"bib25-20230922","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF02968008","article-title":"Mechanism of taxane neurotoxicity","volume":"11","year":"2004","journal-title":"Breast Cancer"},{"key":"bib26-20230922","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrm2183","article-title":"Molecular regulation of angiogenesis and lymphangiogenesis","volume":"8","year":"2007","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000637-201904003-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:50:09Z","timestamp":1695430209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000637-201904003-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":26,"journal-issue":{"issue":"4S","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000001884","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}